Neurovigil

Mountain View, United States Founded: 2007 • Age: 19 yrs
Solution provider for analysis of brain data in medical applications

About Neurovigil

Neurovigil is a Healthcare company based in Mountain View (United States) founded in 2007. Solution provider for analysis of brain data in medical applications. It operates in the Healthcare and Technology sectors. Neurovigil has raised $250 thousand across 3 funding rounds from investors including DFJ, Zone Ventures and Draper Frontier. Neurovigil offers products and services including iBrain Device, SPEARS Algorithm, and Dynamic Signal Processing (DSS). Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Diversified and High Tech. Its legal entity is NeuroVigil, Inc. Its competitors include Bio Rad, Quanterix and Ceribell; 2 of its 3 listed competitors have raised funding.

Company details

NeuroVigil is a neuroscience company focused on the analysis of brain signal or EEG data, which is used in numerous medical applications but is not automated. Its patent-pending and proprietary technology provides automated, and accurate reading and interpretation of EEG data, which is a window to the functioning of the brain. The technology not only automates current manual tasks, but also more than quadruples the amount of useful information obtained from current EEG data, which may lead in the future to neural signatures, or correlates of important disease states, that will be useful in early detection and diagnosis of important medical conditions. NeuroVigil is the winner of the fourth annual DFJ Venture Challenge, a business plan competition sponsored by Draper Fisher Jurvetson (DFJ), DFJ Frontier, and Zone Ventures, that awards 250,000 in seed funding to the winner.

  • Headquarters Mountain View, United States
  • Sectors
    Healthcare
    Technology
  • Website neurovigil.com
  • Social X
  • Legal Name Neurovigil, Inc
Key Metrics
  • Total Equity Funding
    $250K (USD)

    in 3 rounds

  • Investors
    DFJ

    & 2 more

Products & Services of Neurovigil

Neurovigil offers a comprehensive portfolio of products and services, including iBrain Device, SPEARS Algorithm, and Dynamic Signal Processing (DSS).

iBrain Device
Brain Monitoring

Portable EEG for real-time brain activity analysis and disease detection

SPEARS Algorithm
Data Analysis

Software for automated EEG data processing and sleep pattern recognition

Dynamic Signal Processing (DSS)
Signal Processing

Technology for interpreting brain signals in research applications

Funding Insights of Neurovigil

Neurovigil has successfully raised a total of $250K across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $250,000
  • Total Rounds 3
  • First Round $250,000

    (May 2008)

  • Investors Count 3

All 3 funding rounds of Neurovigil with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2015Series B––
May 2011Series A––
–
May 2008$250,000Seed––
Valuation history

3 investors in total: 3 institutional.

Investors in Neurovigil

Neurovigil has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include DFJ, Zone Ventures and Draper Frontier.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
US focused VC firm
dfj.comMenlo Park, United States
zonevc.com
Seed & early-stage micro VC firm investing in the US
draperfrontier.comLos Angeles, United States
Premium access

Investor details for Neurovigil

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Neurovigil

2 people are tracked at Neurovigil (1 in leadership, 1 in team).

NameRoleGroup
Dr. Philip Low
Founder, Chairman, and CEOLeadership
Rebecca Brown
Proud And Fearless Member Of The Manhattan Project For The Brain™Team
Premium access

Complete people profiles for Neurovigil

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Neurovigil

3 dated milestones of Neurovigil across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded Neurovigil is founded.
  2. Funding First funding round of $250K.
  3. Funding Latest funding round, Series B,.

Competitors of Neurovigil

Neurovigil has 3 listed competitors in our database, 2 of them funded. They include Bio Rad, Quanterix and Ceribell.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
bio-rad.com1952Hercules, United States10
Portfolio of products and services for life science research and clinical diagnostic markets
quanterix.com2007Cambridge, United States$99.5M141
Assay kits for ultra-sensitive biomarker detection are developed.
ceribell.com2014Mountain View, United States$187.52M218
Portable EEG devices for point-of-care seizure diagnosis are provided.
Premium access

Detailed competitors of Neurovigil

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Neurovigil

The website of Neurovigil (neurovigil.com) receives about 2.2K visits a month.

  • Monthly visits
    2.2K

    ▲ 8.4% vs previous month

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as Neurovigil (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Neurovigil

Premium access

Complete news archive for Neurovigil

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neurovigil

Neurovigil was founded in 2007 and raised its 1st funding round 1 year after it was founded.

Neurovigil is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.

Neurovigil is a funded company, having raised a total of $250K across 3 funding rounds to date. The company's 1st funding round was a Seed of $250K, raised on May 2008.

NeuroVigil is a neuroscience company focused on the analysis of brain signal or EEG data, which is used in numerous medical applications but is not automated. Its patent-pending and proprietary technology provides automated, and accurate reading and interpretation of EEG data, which is a window to the functioning of the brain. The technology not only automates current manual tasks, but also more than quadruples the amount of useful information obtained from current EEG data, which may lead in the future to neural signatures, or correlates of important disease states, that will be useful in early detection and diagnosis of important medical conditions. NeuroVigil is the winner of the fourth annual DFJ Venture Challenge, a business plan competition sponsored by Draper Fisher Jurvetson (DFJ), DFJ Frontier, and Zone Ventures, that awards 250,000 in seed funding to the winner.

Neurovigil's top competitors include Ceribell, Quanterix and Bio Rad.

Neurovigil offers iBrain Device, SPEARS Algorithm, and Dynamic Signal Processing (DSS).

Neurovigil has 3 investors. Key investors include DFJ, Zone Ventures, and Draper Frontier.

Neurovigil operates through Neurovigil, Inc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available